Cargando…
Pectin in Metabolic Liver Disease
Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824118/ https://www.ncbi.nlm.nih.gov/pubmed/36615814 http://dx.doi.org/10.3390/nu15010157 |
_version_ | 1784866330377191424 |
---|---|
author | Hu, Wanchao Cassard, Anne-Marie Ciocan, Dragos |
author_facet | Hu, Wanchao Cassard, Anne-Marie Ciocan, Dragos |
author_sort | Hu, Wanchao |
collection | PubMed |
description | Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota by fecal microbiota transfer or by application of probiotics or prebiotics/fiber in rodent models and human proof-of-concept trials of NAFLD and ALD have demonstrated its possible contribution to reducing the progression of liver damage. In this review, we address the role of a soluble fiber, pectin, in reducing the development of liver injury in NAFLD and ALD through its impact on gut bacteria. |
format | Online Article Text |
id | pubmed-9824118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98241182023-01-08 Pectin in Metabolic Liver Disease Hu, Wanchao Cassard, Anne-Marie Ciocan, Dragos Nutrients Review Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota by fecal microbiota transfer or by application of probiotics or prebiotics/fiber in rodent models and human proof-of-concept trials of NAFLD and ALD have demonstrated its possible contribution to reducing the progression of liver damage. In this review, we address the role of a soluble fiber, pectin, in reducing the development of liver injury in NAFLD and ALD through its impact on gut bacteria. MDPI 2022-12-29 /pmc/articles/PMC9824118/ /pubmed/36615814 http://dx.doi.org/10.3390/nu15010157 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hu, Wanchao Cassard, Anne-Marie Ciocan, Dragos Pectin in Metabolic Liver Disease |
title | Pectin in Metabolic Liver Disease |
title_full | Pectin in Metabolic Liver Disease |
title_fullStr | Pectin in Metabolic Liver Disease |
title_full_unstemmed | Pectin in Metabolic Liver Disease |
title_short | Pectin in Metabolic Liver Disease |
title_sort | pectin in metabolic liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824118/ https://www.ncbi.nlm.nih.gov/pubmed/36615814 http://dx.doi.org/10.3390/nu15010157 |
work_keys_str_mv | AT huwanchao pectininmetabolicliverdisease AT cassardannemarie pectininmetabolicliverdisease AT ciocandragos pectininmetabolicliverdisease |